A new in-person science and engineering research fair for middle school students from Westchester, Rockland and Putnam counties will premier on Saturday, April 26 at Edgemont High School. The ...

Fianlimab combined with cemiplimab-rwlc (Regeneron’s Libtayo ... M.D., of Sarah Cannon Research Institute in Nashville, Tennessee, and colleagues, wrote in a poster presentation of the data. The ...

The market research report by IMARC encompasses a comprehensive analysis ... in different phases of developing different therapies are Roche, 3M Pharmaceuticals, Regeneron Pharmaceuticals, Sun ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Regeneron hosted a celebration to recognize the achievements of the 17 students selected as the Westchester 2025 Regeneron Science Talent Search Scholars. Beginning in 1942, the contest […] ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...

Emma Wen, a senior at Great Neck North High School, is researching more effective ways to fight pancreatic cancer.

For 17-year-old Emma Wen, a senior at Great Neck North High School, the Regeneron Science Talent Search is more than a passion project. Most adults couldn't understand Wen's research, which could ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

The Regeneron Science Talent Search provides students a national stage to present original research and celebrates the hard work and novel discoveries of young scientists who are bringing a fresh ...

Regeneron Pharmaceuticals ... represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with ...